Brucella suis ΔmapB outer membrane vesicles as an acellular vaccine against systemic and mucosal B. suis infection

IntroductionSwine brucellosis, caused by Brucella suis, is a worldwide infectious zoonotic disease. Currently, there are no available human or porcine vaccines to protect against B. suis infection, which is primarily acquired through the mucosa. We recently described B. suis MapB, the homologous pro...

Full description

Saved in:
Bibliographic Details
Main Authors: Florencia Muñoz González, Magali G. Bialer, Maria L. Cerutti, Silvia M. Estein, Lila Y. Ramis, Pablo C. Baldi, Ángeles Zorreguieta, Mariana C. Ferrero
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1501791/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832539859070222336
author Florencia Muñoz González
Florencia Muñoz González
Magali G. Bialer
Maria L. Cerutti
Silvia M. Estein
Lila Y. Ramis
Pablo C. Baldi
Pablo C. Baldi
Ángeles Zorreguieta
Ángeles Zorreguieta
Mariana C. Ferrero
Mariana C. Ferrero
author_facet Florencia Muñoz González
Florencia Muñoz González
Magali G. Bialer
Maria L. Cerutti
Silvia M. Estein
Lila Y. Ramis
Pablo C. Baldi
Pablo C. Baldi
Ángeles Zorreguieta
Ángeles Zorreguieta
Mariana C. Ferrero
Mariana C. Ferrero
author_sort Florencia Muñoz González
collection DOAJ
description IntroductionSwine brucellosis, caused by Brucella suis, is a worldwide infectious zoonotic disease. Currently, there are no available human or porcine vaccines to protect against B. suis infection, which is primarily acquired through the mucosa. We recently described B. suis MapB, the homologous protein of TamB, the inner membrane component of the TAM system. Our findings indicate that MapB is involved in bacterial cell envelope homeostasis. In this study, we characterize the outer membrane vesicles (OMVs) of B. suis 1330 (wt) and those of B. suis ΔmapB (ΔmapB) mutant strain and evaluate their vaccine potential in mice.MethodsOMVs were isolated using the ultracentrifugation method and characterized through electron microscopy, Dynamic Light Scattering, SDS-PAGE and proteomics. Immunogenicity was assessed by intramuscular immunization of mice with wt OMVs or ΔmapB OMVs, followed by the measurement of antigen-specific antibody levels and functional assays to evaluate the protective capacity of the antibodies. Cellular immunity was assessed by characterizing cytokine secretion through ELISA after in vitro stimulation of spleen cells with heat-killed B. suis. To determine the level of protection conferred by immunization, mice were challenged with virulent B. suis via intraperitoneal or intratracheal routes, and the bacterial load was quantified post-challenge.ResultsDynamic Light Scattering of the OMVs from both strains revealed the presence of spherical structures of 90-130 nm. Proteomic analysis identified 94 and 95 proteins in the wt and ΔmapB OMVs, respectively, including several known Brucella immunogens. Both OMVs showed immunoreactivity with sera from Brucella-infected pigs. Intramuscular immunization of mice with both OMVs induced antigen-specific IgG in serum, with the ΔmapB OMVs group showing higher titers compared to the wt OMVs group. Serum antibodies from both OMVs groups reduced B. suis adherence and invasion of lung epithelial cells and enhanced its phagocytosis by macrophages. Upon in vitro antigen stimulation, spleen cells from mice immunized with ΔmapB OMVs secreted higher levels of interleukin-17 and especially gamma interferon compared to cells from mice immunized with wt OMVs, suggesting the induction of a stronger T helper 1 response in the ΔmapB OMVs group. While immunization with both wt and ΔmapB OMVs achieved the same level of protection following intratracheal infection with B. suis (p<0.01), immunization with ΔmapB OMVs provided higher levels of protection against intraperitoneal infection.DiscussionOverall, these results demonstrate that the B. suis ΔmapB OMVs are immunogenic and capable of inducing both cellular and humoral immune responses that protect against mucosal and systemic B. suis challenges.
format Article
id doaj-art-e91a711b31374f3799a3f063e46450ad
institution Kabale University
issn 1664-3224
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj-art-e91a711b31374f3799a3f063e46450ad2025-02-05T09:07:12ZengFrontiers Media S.A.Frontiers in Immunology1664-32242025-01-011510.3389/fimmu.2024.15017911501791Brucella suis ΔmapB outer membrane vesicles as an acellular vaccine against systemic and mucosal B. suis infectionFlorencia Muñoz González0Florencia Muñoz González1Magali G. Bialer2Maria L. Cerutti3Silvia M. Estein4Lila Y. Ramis5Pablo C. Baldi6Pablo C. Baldi7Ángeles Zorreguieta8Ángeles Zorreguieta9Mariana C. Ferrero10Mariana C. Ferrero11Facultad de Farmacia y Bioquímica, Cátedra de Inmunología, Universidad de Buenos Aires, Buenos Aires, ArgentinaInstituto de Estudios de la Inmunidad Humoral (IDEHU), CONICET-Universidad de Buenos Aires, Buenos Aires, ArgentinaFundación Instituto Leloir (FIL), IIBBA-CONICET (CONICET-FIL), Buenos Aires, ArgentinaCentro de Rediseño e Ingeniería de proteínas (CRIP), Universidad Nacional de San Martín, Buenos Aires, ArgentinaLaboratorio de Inmunología, Departamento de Sanidad Animal y Medicina Preventiva (SAMP), Centro de Investigación Veterinaria Tandil (CIVETAN-CONICET-CICPBA), Facultad de Ciencias Veterinarias (FCV), Universidad Nacional del Centro de la Provincia de Buenos Aires (UNCPBA), Tandil, Buenos Aires, ArgentinaFundación Instituto Leloir (FIL), IIBBA-CONICET (CONICET-FIL), Buenos Aires, ArgentinaFacultad de Farmacia y Bioquímica, Cátedra de Inmunología, Universidad de Buenos Aires, Buenos Aires, ArgentinaInstituto de Estudios de la Inmunidad Humoral (IDEHU), CONICET-Universidad de Buenos Aires, Buenos Aires, ArgentinaFundación Instituto Leloir (FIL), IIBBA-CONICET (CONICET-FIL), Buenos Aires, ArgentinaDepartamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Buenos Aires, ArgentinaFacultad de Farmacia y Bioquímica, Cátedra de Inmunología, Universidad de Buenos Aires, Buenos Aires, ArgentinaInstituto de Estudios de la Inmunidad Humoral (IDEHU), CONICET-Universidad de Buenos Aires, Buenos Aires, ArgentinaIntroductionSwine brucellosis, caused by Brucella suis, is a worldwide infectious zoonotic disease. Currently, there are no available human or porcine vaccines to protect against B. suis infection, which is primarily acquired through the mucosa. We recently described B. suis MapB, the homologous protein of TamB, the inner membrane component of the TAM system. Our findings indicate that MapB is involved in bacterial cell envelope homeostasis. In this study, we characterize the outer membrane vesicles (OMVs) of B. suis 1330 (wt) and those of B. suis ΔmapB (ΔmapB) mutant strain and evaluate their vaccine potential in mice.MethodsOMVs were isolated using the ultracentrifugation method and characterized through electron microscopy, Dynamic Light Scattering, SDS-PAGE and proteomics. Immunogenicity was assessed by intramuscular immunization of mice with wt OMVs or ΔmapB OMVs, followed by the measurement of antigen-specific antibody levels and functional assays to evaluate the protective capacity of the antibodies. Cellular immunity was assessed by characterizing cytokine secretion through ELISA after in vitro stimulation of spleen cells with heat-killed B. suis. To determine the level of protection conferred by immunization, mice were challenged with virulent B. suis via intraperitoneal or intratracheal routes, and the bacterial load was quantified post-challenge.ResultsDynamic Light Scattering of the OMVs from both strains revealed the presence of spherical structures of 90-130 nm. Proteomic analysis identified 94 and 95 proteins in the wt and ΔmapB OMVs, respectively, including several known Brucella immunogens. Both OMVs showed immunoreactivity with sera from Brucella-infected pigs. Intramuscular immunization of mice with both OMVs induced antigen-specific IgG in serum, with the ΔmapB OMVs group showing higher titers compared to the wt OMVs group. Serum antibodies from both OMVs groups reduced B. suis adherence and invasion of lung epithelial cells and enhanced its phagocytosis by macrophages. Upon in vitro antigen stimulation, spleen cells from mice immunized with ΔmapB OMVs secreted higher levels of interleukin-17 and especially gamma interferon compared to cells from mice immunized with wt OMVs, suggesting the induction of a stronger T helper 1 response in the ΔmapB OMVs group. While immunization with both wt and ΔmapB OMVs achieved the same level of protection following intratracheal infection with B. suis (p<0.01), immunization with ΔmapB OMVs provided higher levels of protection against intraperitoneal infection.DiscussionOverall, these results demonstrate that the B. suis ΔmapB OMVs are immunogenic and capable of inducing both cellular and humoral immune responses that protect against mucosal and systemic B. suis challenges.https://www.frontiersin.org/articles/10.3389/fimmu.2024.1501791/fullouter membrane vesiclesBrucella suisvaccineTAMrespiratory infection
spellingShingle Florencia Muñoz González
Florencia Muñoz González
Magali G. Bialer
Maria L. Cerutti
Silvia M. Estein
Lila Y. Ramis
Pablo C. Baldi
Pablo C. Baldi
Ángeles Zorreguieta
Ángeles Zorreguieta
Mariana C. Ferrero
Mariana C. Ferrero
Brucella suis ΔmapB outer membrane vesicles as an acellular vaccine against systemic and mucosal B. suis infection
Frontiers in Immunology
outer membrane vesicles
Brucella suis
vaccine
TAM
respiratory infection
title Brucella suis ΔmapB outer membrane vesicles as an acellular vaccine against systemic and mucosal B. suis infection
title_full Brucella suis ΔmapB outer membrane vesicles as an acellular vaccine against systemic and mucosal B. suis infection
title_fullStr Brucella suis ΔmapB outer membrane vesicles as an acellular vaccine against systemic and mucosal B. suis infection
title_full_unstemmed Brucella suis ΔmapB outer membrane vesicles as an acellular vaccine against systemic and mucosal B. suis infection
title_short Brucella suis ΔmapB outer membrane vesicles as an acellular vaccine against systemic and mucosal B. suis infection
title_sort brucella suis δmapb outer membrane vesicles as an acellular vaccine against systemic and mucosal b suis infection
topic outer membrane vesicles
Brucella suis
vaccine
TAM
respiratory infection
url https://www.frontiersin.org/articles/10.3389/fimmu.2024.1501791/full
work_keys_str_mv AT florenciamunozgonzalez brucellasuisdmapboutermembranevesiclesasanacellularvaccineagainstsystemicandmucosalbsuisinfection
AT florenciamunozgonzalez brucellasuisdmapboutermembranevesiclesasanacellularvaccineagainstsystemicandmucosalbsuisinfection
AT magaligbialer brucellasuisdmapboutermembranevesiclesasanacellularvaccineagainstsystemicandmucosalbsuisinfection
AT marialcerutti brucellasuisdmapboutermembranevesiclesasanacellularvaccineagainstsystemicandmucosalbsuisinfection
AT silviamestein brucellasuisdmapboutermembranevesiclesasanacellularvaccineagainstsystemicandmucosalbsuisinfection
AT lilayramis brucellasuisdmapboutermembranevesiclesasanacellularvaccineagainstsystemicandmucosalbsuisinfection
AT pablocbaldi brucellasuisdmapboutermembranevesiclesasanacellularvaccineagainstsystemicandmucosalbsuisinfection
AT pablocbaldi brucellasuisdmapboutermembranevesiclesasanacellularvaccineagainstsystemicandmucosalbsuisinfection
AT angeleszorreguieta brucellasuisdmapboutermembranevesiclesasanacellularvaccineagainstsystemicandmucosalbsuisinfection
AT angeleszorreguieta brucellasuisdmapboutermembranevesiclesasanacellularvaccineagainstsystemicandmucosalbsuisinfection
AT marianacferrero brucellasuisdmapboutermembranevesiclesasanacellularvaccineagainstsystemicandmucosalbsuisinfection
AT marianacferrero brucellasuisdmapboutermembranevesiclesasanacellularvaccineagainstsystemicandmucosalbsuisinfection